CHARLES MINARD to Thrombocytopenia
This is a "connection" page, showing publications CHARLES MINARD has written about Thrombocytopenia.
Connection Strength
0.033
-
A phase 1 study of prexasertib (LY2606368), a CHK1/2 inhibitor, in pediatric patients with recurrent or refractory solid tumors, including CNS tumors: A report from the Children's Oncology Group Pediatric Early Phase Clinical Trials Network (ADVL1515). Pediatr Blood Cancer. 2021 09; 68(9):e29065.
Score: 0.033